Reuters: Hot Stocks: BRIEF-Isis Pharma in premarket ater FDA advisory panel backs Kynamro drug

Reuters: Hot Stocks Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

BRIEF-Isis Pharma in premarket ater FDA advisory panel backs Kynamro drug Oct 19th 2012, 11:36 NEW YORK | Fri Oct 19, 2012 7:36am EDT NEW YORK Oct 19 (Reuters) - Isis Pharmaceuticals Inc : * Isis Pharma up 6.6 percent to $10.25 in premarket ater FDA advisory panel backs Kynamro drug for genetic disorder homozygous familial hypercholesterolemia

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions